0001104659-20-117614.txt : 20201023 0001104659-20-117614.hdr.sgml : 20201023 20201023132306 ACCESSION NUMBER: 0001104659-20-117614 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201023 FILED AS OF DATE: 20201023 DATE AS OF CHANGE: 20201023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPADOPOULOS STELIOS CENTRAL INDEX KEY: 0001202098 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39650 FILM NUMBER: 201257060 MAIL ADDRESS: STREET 1: 3 SOMERSET DRIVE SOUTH CITY: GREAT NECK STATE: NY ZIP: 11020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eucrates Biomedical Acquisition Corp. CENTRAL INDEX KEY: 0001822929 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 BUSINESS ADDRESS: STREET 1: 250 WEST 55TH STREET, SUITE 13D CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 710-5220 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET, SUITE 13D CITY: NEW YORK STATE: NY ZIP: 10019 3 1 tm2034126-6_3.xml FORM 3 X0206 3 2020-10-23 0 0001822929 Eucrates Biomedical Acquisition Corp. EUCR 0001202098 PAPADOPOULOS STELIOS C/O EUCRATES BIOMEDICAL ACQUISITION CORP 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 1 0 1 0 Ordinary Shares 2875000 I See Footnote These shares represent ordinary shares held by the issuer's sponsor, Eucrates LLC. The shares held by the sponsor are beneficially owned by each of Parag Saxena and Stelios Papadopoulos, the issuer's Chief Executive Officer and Chairman, respectively, and the managing members of the sponsor, who have joint voting and dispositive power over the shares held by the sponsor. These shares include up to an aggregate of 375,000 ordinary shares subject to forfeiture by the sponsor to the extent that the underwriters' over-allotment option is not exercised in full. Mr. Saxena and Mr. Papadopoulos disclaim beneficial ownership over any securities owned by the sponsor in which they do not have any pecuniary interest. /s/ Stelios Papadopoulos 2020-10-23